Global Home Infusion Therapy Market Overview

The Global Home Infusion Therapy Market size is expected to grow from USD 21.57 billion in 2022 to USD 35.78 billion by 2030, at a CAGR of 6.53% during the forecast period (2023-2030).

The intravenous or subcutaneous injection of medications or biologicals to a patient at home is termed home infusion therapy. The medicine (antivirals, immune globulin), equipment (pump), and supplies (tubing and catheters) are required for home infusion. Oral medication can be replaced by home infusion therapy. Nurses typically educate patients or caregivers on how to self-administer the medicine, educate them on side effects and therapeutic goals, and visit the infusion site regularly to monitor the infusion site and change the dressing. Patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if required, home health organizations must all work together to make the home infusion process a success. Traditionally, this procedure has been utilized in hospitals, and individuals can choose from a variety of home infusion treatments provided by professionals. Infusion therapy is used to treat chronic or serious infections that cannot be cured with antibiotics. Cancers and the divergent pain induced by cancer, dehydration, diarrhea, vomiting, and other complex disorders are examples of such causes. The growing number of patients opting for home treatment solutions is expected to boost the growth of the market over the forecast period.

Market Dynamics and Key Factors of Home Infusion Therapy:

Drivers:

Hospital-Like Care at Home
Patients can receive an innovative and comprehensive set of services with a variety of care alternatives when they choose home infusion services. Home services can help patients to avoid extended hospital stays and high medical fees by providing care in the comfort of the home. Individuals can receive IV infusions in a comfortable and safe atmosphere as part of several infusion therapies. With the guidance of a trustworthy health provider, a patient recovering from surgery or undergoing surgery therapy can access a variety of home care infusion services. Professionals can assist patients with all types of infusions, from the first interaction with the client to providing professional home therapy.

To reduce the strain on the primary healthcare services
The market is expected to grow in response to the growing need to shorten inpatient stays. According to the American Hospital Association, there were approximately 36,241,815 hospital admissions in all US hospitals in 2019. This has prompted the development of ways for administering infusion therapy at home or in other healthcare settings, which is expected to boost the market growth. While hospitals have quickly adopted smart infusion pumps with useful features like EHR connection, drug libraries, and medication safety software, most home infusion providers still use classic infusion pumps. However, due to rising demand, there has been a growing trend for equipment upgrades, particularly in developed countries thus, supporting the development of the home infusion therapy market over the forecast period.

Restraints:

Third-Party service providers and low reimbursement policies

The issue of fragmented care may develop in the home infusion setting if the home infusion provider is a third-party company that is not part of the patient's primary care team. Concerns about the patient's limited access to their care team may also cause issues, as eliminating the requirement for patients to visit the clinic for each infusion reduces their interaction with their provider. Other issues that may develop include the patient's potential limited access to emergency services if a negative reaction or adverse event (AE) occurs during the infusion thus, hampering the growth of the market over the projected timeframe.

Opportunities:

Growing Geriatric Population
According to the United Nations, the world's population will grow by one billion people by 2025, with roughly a third of them being 65 or older as life expectancy rises. Middle-class comforts and urbanization are also on the rise, potentially leading to more sedentary lifestyles and chronic illnesses. There is concern that all of this will place a further strain on the global health system's ability to administer and pay for care. As a result, there has been a significant shift in healthcare toward a more patient-centered, community-based approach. Regulations in the healthcare industry have supported the growth of the home infusion therapy market. For instance, healthcare systems in the USA are implementing new guidelines to support home infusion therapies thus, creating a lucrative opportunity for the market players.

Market Segmentation

By product type, the infusion pump segment is anticipated to have the highest share of the home infusion therapy market. It is projected to record a 5.4% CAGR and reach USD 18.2 billion by the end of the analysis period. Infusion pumps have numerous benefits over manual fluid administration, including the ability to give fluids in very small quantities and at precisely programmed rates or automatic intervals. They can be utilized to administer nutrients or pharmaceuticals like insulin or other hormones, antibiotics, chemotherapeutic treatments, and pain relievers. Large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps are among the various types of infusion pumps available.

By infusion type, the continuous segment is estimated to dominate the infusion therapy market. Continuous infusion maintains a constant concentration of microbubbles, lowering the risk of artifacts. If there is a steady-state concentration of contrast, it is also possible to compute myocardial blood flow, as both myocardial blood volume and microbubble velocity can be calculated. Continuous infusion strategies have been found in studies to be the best options for drug administration in cancer patients thus, supporting the growth of the segment.

By application, the anti-infective segment is anticipated to lead the growth of the home infusion therapy market. One of the most regularly prescribed home infusion therapies is anti-infective therapy (antibiotics, antifungals, and antivirals), which can be safely managed at home. Cystic fibrosis, Lyme disease, Osteomyelitis, and other infections that require long-term anti-infective therapy can all be caused by a variety of causes. If not treated properly, each of these clinical disorders can lead to unnecessary hospitalization and/or emergency room visits. These disorders can be treated at home using infusion therapy, which can help avert life-threatening situations thus, boosting the development of the segment.

Players Covered in Home Infusion Therapy market are :

• CVS/Coram
• Option Care Health
• BriovaRx/Diplomat (UnitedHealth Optum)
• PharMerica
• Fresenius Kabi
• ICU Medical Inc.
• B. Braun Melsungen AG
• Baxter
• BD
• Caesarea Medical Electronics
• Smiths Medical
• Terumo Corporation
• JMS Co. Ltd and others major players.

Regional Analysis of Home Infusion Therapy Market:

The North American region is anticipated to dominate the home infusion therapy market during the forecasted timeframe. The growing prevalence of chronic diseases and the increasing burden on primary healthcare infrastructure are the main factors supporting the growth of the market. Multiple sclerosis, rheumatoid arthritis, hemophilia, immunological deficiencies, and neurological disorders are common in this region. According to a recent NHIA study, home infusion and specialty providers in the United States catered to more than 3 million patients in 2019, up 300 percent from the last industry study in 2008. According to NHIA, home and specialty infusion will be a $19 billion business by 2020, with over 900 providers serving 3.2 million patients. This number is expected to grow in the projected timeframe thus strengthening the development of the home infusion therapy market.

The European region is estimated to have the second-highest share of the home infusion therapy market in the forecasted timeframe. In Europe, demographic, epidemiological, socioeconomic, and cultural developments are altering traditional patient care patterns. Home infusion therapies are becoming more popular as a result of changing demographics. Shortly, the population structure of European Union (EU) countries will alter dramatically. The proportion of elderly and very elderly people is expected to increase. According to Statista, by 2025 people between 40-and 44 will account for the largest age group (52.7 million). The rising geriatric population is the main factor propelling the growth of the home infusion therapy market in this region.

The home infusion therapy market in the Asia-Pacific region is anticipated to develop at the highest CAGR attributed to the high density of the population. China, India, Japan, Indonesia, Pakistan, South Korea, and Vietnam are highly populated countries. To reduce the strain on primary healthcare facilities, hospitals are promoting the usage of home infusion therapies for patients that can be treated at home. Chronic diseases such as rheumatoid arthritis, cancer, mental disorders, and cardiovascular are common in this region. These diseases in their early stages can be treated at home under the proper guidance of a healthcare professional. The growing prevalence of chronic diseases coupled with a rise in awareness about the benefits of home infusion therapies is expected to boost the growth of the market during the forecast period.

Recent Industry Developments in Home Infusion Therapy Market:

• In December 2021, the acquisition of Hillrom by Baxter International Inc. has been completed. This acquisition will aid the company in expanding its geographic reach and integrating medical device technologies to improve patient care, reduce costs, and streamline operations.
• In November 2021, Eitan Medical has been appointed to the NHIA's Future of Infusion Advisory Council (FIAC). The FIAC is a strategic advisory organization made up of manufacturers and service providers with a presence in the home and alternate site infusion industry.
• In March 2020, Lincare, a subsidiary of Linde plc, has announced the acquisition of KabaFusion's home infusion assets. KabaFusion's position as the leading clinician-led home infusion company in the United States is strengthened by this strategic alliance.

COVID-19 Impact on Home Infusion Therapy Market:

COVID-19 disrupted daily people's lives all around the world. Many patients were hospitalized as a result of COVID-19, and many of them needed to be put on ventilators. Patients needed to be in areas where they wouldn't be able to infect other patients or health care personnel treating them, which required a lot of space in hospitals. Many companies began partnering with health systems to move patients from the hospital to in-home care as rapidly as possible to assist hospitals with the rising demand for space and beds. Many additional recommendations were introduced to general operations to continue providing patient care while preserving the safety of the patient and nurse/provider. To protect patients and employees, the National Home Infusion Association (NHIA) implemented numerous critical suggestions. Since the outbreak of COVID-19, the use of in-home care and home infusions has increased to free up space in hospitals and ensure patient safety. After the pandemic, it is projected that home infusions will continue to be needed and will become the new standard for patients thus, supporting the development of the home infusion therapy market over the forecasted timeframe.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Infusion Type
 3.3 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Home Infusion Therapy Market by Type
 5.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
 5.2 Home Infusion Therapy Market Overview
 5.3 IV Cannulas
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 IV Cannulas: Grographic Segmentation
 5.4 Infusion Pumps
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Infusion Pumps: Grographic Segmentation
 5.5 Needleless Connectors
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Needleless Connectors: Grographic Segmentation
 5.6 Intravenous Sets
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Intravenous Sets: Grographic Segmentation

Chapter 6: Home Infusion Therapy Market by Infusion Type
 6.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
 6.2 Home Infusion Therapy Market Overview
 6.3 Continuous
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Continuous: Grographic Segmentation
 6.4 Secondary IV
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Secondary IV: Grographic Segmentation
 6.5 IV Push
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 IV Push: Grographic Segmentation

Chapter 7: Home Infusion Therapy Market by Application
 7.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
 7.2 Home Infusion Therapy Market Overview
 7.3 Anti-Infective
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Anti-Infective: Grographic Segmentation
 7.4 Endocrinology
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Endocrinology: Grographic Segmentation
 7.5 Enteral Nutrition
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Enteral Nutrition: Grographic Segmentation
 7.6 Parenteral Nutrition
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Parenteral Nutrition: Grographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Home Infusion Therapy Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Home Infusion Therapy Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Home Infusion Therapy Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 CVS/CORAM
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 OPTION CARE HEALTH
 8.4 BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM)
 8.5 PHARMERICA
 8.6 FRESENIUS KABI
 8.7 ICU MEDICAL INC.
 8.8 B. BRAUN MELSUNGEN AG
 8.9 BAXTER
 8.10 BD
 8.11 CAESAREA MEDICAL ELECTRONICS
 8.12 SMITHS MEDICAL
 8.13 TERUMO CORPORATION
 8.14 JMS CO. LTD.
 8.15 OTHERS MAJOR PLAYERS

Chapter 9: Global Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 IV Cannulas
  9.2.2 Infusion Pumps
  9.2.3 Needleless Connectors
  9.2.4 Intravenous Sets
 9.3 Historic and Forecasted Market Size By Infusion Type
  9.3.1 Continuous
  9.3.2 Secondary IV
  9.3.3 IV Push
 9.4 Historic and Forecasted Market Size By Application
  9.4.1 Anti-Infective
  9.4.2 Endocrinology
  9.4.3 Enteral Nutrition
  9.4.4 Parenteral Nutrition
  9.4.5 Others

Chapter 10: North America Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 IV Cannulas
  10.4.2 Infusion Pumps
  10.4.3 Needleless Connectors
  10.4.4 Intravenous Sets
 10.5 Historic and Forecasted Market Size By Infusion Type
  10.5.1 Continuous
  10.5.2 Secondary IV
  10.5.3 IV Push
 10.6 Historic and Forecasted Market Size By Application
  10.6.1 Anti-Infective
  10.6.2 Endocrinology
  10.6.3 Enteral Nutrition
  10.6.4 Parenteral Nutrition
  10.6.5 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 IV Cannulas
  11.4.2 Infusion Pumps
  11.4.3 Needleless Connectors
  11.4.4 Intravenous Sets
 11.5 Historic and Forecasted Market Size By Infusion Type
  11.5.1 Continuous
  11.5.2 Secondary IV
  11.5.3 IV Push
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Anti-Infective
  11.6.2 Endocrinology
  11.6.3 Enteral Nutrition
  11.6.4 Parenteral Nutrition
  11.6.5 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 IV Cannulas
  12.4.2 Infusion Pumps
  12.4.3 Needleless Connectors
  12.4.4 Intravenous Sets
 12.5 Historic and Forecasted Market Size By Infusion Type
  12.5.1 Continuous
  12.5.2 Secondary IV
  12.5.3 IV Push
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Anti-Infective
  12.6.2 Endocrinology
  12.6.3 Enteral Nutrition
  12.6.4 Parenteral Nutrition
  12.6.5 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 IV Cannulas
  13.4.2 Infusion Pumps
  13.4.3 Needleless Connectors
  13.4.4 Intravenous Sets
 13.5 Historic and Forecasted Market Size By Infusion Type
  13.5.1 Continuous
  13.5.2 Secondary IV
  13.5.3 IV Push
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Anti-Infective
  13.6.2 Endocrinology
  13.6.3 Enteral Nutrition
  13.6.4 Parenteral Nutrition
  13.6.5 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Home Infusion Therapy Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 IV Cannulas
  14.4.2 Infusion Pumps
  14.4.3 Needleless Connectors
  14.4.4 Intravenous Sets
 14.5 Historic and Forecasted Market Size By Infusion Type
  14.5.1 Continuous
  14.5.2 Secondary IV
  14.5.3 IV Push
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Anti-Infective
  14.6.2 Endocrinology
  14.6.3 Enteral Nutrition
  14.6.4 Parenteral Nutrition
  14.6.5 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. HOME INFUSION THERAPY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. HOME INFUSION THERAPY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. HOME INFUSION THERAPY MARKET COMPETITIVE RIVALRY
TABLE 005. HOME INFUSION THERAPY MARKET THREAT OF NEW ENTRANTS
TABLE 006. HOME INFUSION THERAPY MARKET THREAT OF SUBSTITUTES
TABLE 007. HOME INFUSION THERAPY MARKET BY TYPE
TABLE 008. IV CANNULAS MARKET OVERVIEW (2016-2028)
TABLE 009. INFUSION PUMPS MARKET OVERVIEW (2016-2028)
TABLE 010. NEEDLELESS CONNECTORS MARKET OVERVIEW (2016-2028)
TABLE 011. INTRAVENOUS SETS MARKET OVERVIEW (2016-2028)
TABLE 012. HOME INFUSION THERAPY MARKET BY INFUSION TYPE
TABLE 013. CONTINUOUS MARKET OVERVIEW (2016-2028)
TABLE 014. SECONDARY IV MARKET OVERVIEW (2016-2028)
TABLE 015. IV PUSH MARKET OVERVIEW (2016-2028)
TABLE 016. HOME INFUSION THERAPY MARKET BY APPLICATION
TABLE 017. ANTI-INFECTIVE MARKET OVERVIEW (2016-2028)
TABLE 018. ENDOCRINOLOGY MARKET OVERVIEW (2016-2028)
TABLE 019. ENTERAL NUTRITION MARKET OVERVIEW (2016-2028)
TABLE 020. PARENTERAL NUTRITION MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA HOME INFUSION THERAPY MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA HOME INFUSION THERAPY MARKET, BY INFUSION TYPE (2016-2028)
TABLE 024. NORTH AMERICA HOME INFUSION THERAPY MARKET, BY APPLICATION (2016-2028)
TABLE 025. N HOME INFUSION THERAPY MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE HOME INFUSION THERAPY MARKET, BY TYPE (2016-2028)
TABLE 027. EUROPE HOME INFUSION THERAPY MARKET, BY INFUSION TYPE (2016-2028)
TABLE 028. EUROPE HOME INFUSION THERAPY MARKET, BY APPLICATION (2016-2028)
TABLE 029. HOME INFUSION THERAPY MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC HOME INFUSION THERAPY MARKET, BY TYPE (2016-2028)
TABLE 031. ASIA PACIFIC HOME INFUSION THERAPY MARKET, BY INFUSION TYPE (2016-2028)
TABLE 032. ASIA PACIFIC HOME INFUSION THERAPY MARKET, BY APPLICATION (2016-2028)
TABLE 033. HOME INFUSION THERAPY MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA HOME INFUSION THERAPY MARKET, BY TYPE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA HOME INFUSION THERAPY MARKET, BY INFUSION TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA HOME INFUSION THERAPY MARKET, BY APPLICATION (2016-2028)
TABLE 037. HOME INFUSION THERAPY MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA HOME INFUSION THERAPY MARKET, BY TYPE (2016-2028)
TABLE 039. SOUTH AMERICA HOME INFUSION THERAPY MARKET, BY INFUSION TYPE (2016-2028)
TABLE 040. SOUTH AMERICA HOME INFUSION THERAPY MARKET, BY APPLICATION (2016-2028)
TABLE 041. HOME INFUSION THERAPY MARKET, BY COUNTRY (2016-2028)
TABLE 042. CVS/CORAM: SNAPSHOT
TABLE 043. CVS/CORAM: BUSINESS PERFORMANCE
TABLE 044. CVS/CORAM: PRODUCT PORTFOLIO
TABLE 045. CVS/CORAM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. OPTION CARE HEALTH: SNAPSHOT
TABLE 046. OPTION CARE HEALTH: BUSINESS PERFORMANCE
TABLE 047. OPTION CARE HEALTH: PRODUCT PORTFOLIO
TABLE 048. OPTION CARE HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM): SNAPSHOT
TABLE 049. BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM): BUSINESS PERFORMANCE
TABLE 050. BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM): PRODUCT PORTFOLIO
TABLE 051. BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. PHARMERICA: SNAPSHOT
TABLE 052. PHARMERICA: BUSINESS PERFORMANCE
TABLE 053. PHARMERICA: PRODUCT PORTFOLIO
TABLE 054. PHARMERICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. FRESENIUS KABI: SNAPSHOT
TABLE 055. FRESENIUS KABI: BUSINESS PERFORMANCE
TABLE 056. FRESENIUS KABI: PRODUCT PORTFOLIO
TABLE 057. FRESENIUS KABI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. ICU MEDICAL INC.: SNAPSHOT
TABLE 058. ICU MEDICAL INC.: BUSINESS PERFORMANCE
TABLE 059. ICU MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 060. ICU MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. B. BRAUN MELSUNGEN AG: SNAPSHOT
TABLE 061. B. BRAUN MELSUNGEN AG: BUSINESS PERFORMANCE
TABLE 062. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 063. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. BAXTER: SNAPSHOT
TABLE 064. BAXTER: BUSINESS PERFORMANCE
TABLE 065. BAXTER: PRODUCT PORTFOLIO
TABLE 066. BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. BD: SNAPSHOT
TABLE 067. BD: BUSINESS PERFORMANCE
TABLE 068. BD: PRODUCT PORTFOLIO
TABLE 069. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. CAESAREA MEDICAL ELECTRONICS: SNAPSHOT
TABLE 070. CAESAREA MEDICAL ELECTRONICS: BUSINESS PERFORMANCE
TABLE 071. CAESAREA MEDICAL ELECTRONICS: PRODUCT PORTFOLIO
TABLE 072. CAESAREA MEDICAL ELECTRONICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. SMITHS MEDICAL: SNAPSHOT
TABLE 073. SMITHS MEDICAL: BUSINESS PERFORMANCE
TABLE 074. SMITHS MEDICAL: PRODUCT PORTFOLIO
TABLE 075. SMITHS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. TERUMO CORPORATION: SNAPSHOT
TABLE 076. TERUMO CORPORATION: BUSINESS PERFORMANCE
TABLE 077. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 078. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. JMS CO. LTD.: SNAPSHOT
TABLE 079. JMS CO. LTD.: BUSINESS PERFORMANCE
TABLE 080. JMS CO. LTD.: PRODUCT PORTFOLIO
TABLE 081. JMS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. OTHERS MAJOR PLAYERS: SNAPSHOT
TABLE 082. OTHERS MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 083. OTHERS MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 084. OTHERS MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. HOME INFUSION THERAPY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. HOME INFUSION THERAPY MARKET OVERVIEW BY TYPE
FIGURE 012. IV CANNULAS MARKET OVERVIEW (2016-2028)
FIGURE 013. INFUSION PUMPS MARKET OVERVIEW (2016-2028)
FIGURE 014. NEEDLELESS CONNECTORS MARKET OVERVIEW (2016-2028)
FIGURE 015. INTRAVENOUS SETS MARKET OVERVIEW (2016-2028)
FIGURE 016. HOME INFUSION THERAPY MARKET OVERVIEW BY INFUSION TYPE
FIGURE 017. CONTINUOUS MARKET OVERVIEW (2016-2028)
FIGURE 018. SECONDARY IV MARKET OVERVIEW (2016-2028)
FIGURE 019. IV PUSH MARKET OVERVIEW (2016-2028)
FIGURE 020. HOME INFUSION THERAPY MARKET OVERVIEW BY APPLICATION
FIGURE 021. ANTI-INFECTIVE MARKET OVERVIEW (2016-2028)
FIGURE 022. ENDOCRINOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 023. ENTERAL NUTRITION MARKET OVERVIEW (2016-2028)
FIGURE 024. PARENTERAL NUTRITION MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA HOME INFUSION THERAPY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE HOME INFUSION THERAPY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC HOME INFUSION THERAPY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA HOME INFUSION THERAPY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA HOME INFUSION THERAPY MARKET OVERVIEW BY COUNTRY (2016-2028)